Asosiy kontentga oʻtish
AkademIndex

Mahsulotlar

Ishlab chiquvchilar uchun

AkademBaseEkotizim uchun ochiq API

Histone Deacetylase Inhibitors Research

13 ta ish

  1. Remodeling “cold” tumor immune microenvironment via epigenetic-based therapy using targeted liposomes with in situ formed albumin corona

    Yang He, Yuefei Fang, Meng Zhang +7

    MaqolaHistone Deacetylase Inhibitors ResearchActa Pharmaceutica Sinica B20214 iqtibos
    ABI

  2. Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms

    Bushra Faryal, Zain Ul Abideen, Muhammad Irfan +4

    MaqolaProtein Degradation and InhibitorsBiomolecules20262 iqtibos
    ABI

  3. Demethyldihydroglycyrin tetraacetate

    Shakhnoza S. Azimova, Валентина И. Виноградова

    BobHyperglycemia and glycemic control in critically ill and hospitalized patients20120 iqtibos
    ABI

  4. 28-epi-Isocyasterone

    Shakhnoza S. Azimova

    BobOrganic Chemistry Cycloaddition Reactions20120 iqtibos
    ABI

  5. Nanotherapeutic macrophage-based immunotherapy for the peritoneal carcinomatosis of lung cancer

    Yonghui Wang, Binfan Chen, Zhidi He +7

    MaqolaHistone Deacetylase Inhibitors ResearchNanoscale20210 iqtibos
    ABI

  6. The Effect of Ecdystene on the Activity of Matrix Metalloproteinases in Experimental Alloxan Diabetes in Rats

    D. Tursunov, Rixsi A. Sabirova, М. У. Кульманова +5

    MaqolaProtease and Inhibitor MechanismsBioNanoScience20210 iqtibos
    ABI

  7. A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance

    Anggraeni Endah Kusumaningrum, Sarce Makaba, Eyhab Ali +6

    MaqolaColorectal Cancer Treatments and StudiesCell Biochemistry and Function20240 iqtibos
    ABI

  8. Ubiquitylation in the development of somatic diseases: a mechanism of cellular regulation and a new therapeutic target

    Александр Ураков, Anton Tyurin, V. S. Shchekin +4

    MaqolaUbiquitin and proteasome pathwaysReviews on Clinical Pharmacology and Drug Therapy20240 iqtibos
    ABI

  9. AML-489: Combination of Azacitidine and Venetoclax in Patients With Acute Myeloid Leukemia: A Single-Center Experience

    Farhodjon Tashtemirov, Z.V. Yunusova, M Islamov +3

    MaqolaAcute Myeloid Leukemia ResearchClinical Lymphoma Myeloma & Leukemia20250 iqtibos
    ABI

  10. Therapeutic innovations: targeting ROS production in AML with natural and synthetic compounds

    Mohammed H. Mohammed, Raed Fanoukh Aboqader Al-Aouadi, Subasini Uthirapathy +7

    Sharh maqolaHistone Deacetylase Inhibitors ResearchNaunyn-Schmiedeberg s Archives of Pharmacology20250 iqtibos
    ABI

  11. Epigenetic regulation of EZH2 by ncRNAs: mechanisms and oncogenic implications

    Hussein Salim Abed, N. Esanmurodova, Abhinav Kumar +6

    Sharh maqolaEpigenetics and DNA MethylationNaunyn-Schmiedeberg s Archives of Pharmacology20250 iqtibos
    ABI

  12. Epigenetic clocks and biological aging acceleration in early-onset hypertension

    Alisher Axrorov, Elvina Midatovna Sharipova, Nodirbek Xamidov +3

    MaqolaEpigenetics and DNA MethylationZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI

  13. Epigenetic clocks and biological aging acceleration in early-onset hypertension

    Alisher Axrorov, Elvina Midatovna Sharipova, Nodirbek Xamidov +3

    MaqolaEpigenetics and DNA MethylationZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
    ABI